AngioDynamics, Inc. (ANGO) CFO Sells $41,746.67 in Stock

AngioDynamics, Inc. (NASDAQ:ANGO) CFO Michael Greiner sold 1,939 shares of the business’s stock in a transaction that occurred on Wednesday, November 7th. The stock was sold at an average price of $21.53, for a total value of $41,746.67. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Shares of ANGO opened at $21.38 on Friday. The company has a market capitalization of $805.91 million, a PE ratio of 28.89 and a beta of 0.75. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.55 and a current ratio of 2.64. AngioDynamics, Inc. has a one year low of $15.16 and a one year high of $24.49.

AngioDynamics (NASDAQ:ANGO) last announced its earnings results on Thursday, September 27th. The medical instruments supplier reported $0.16 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.02). The business had revenue of $85.34 million during the quarter, compared to analyst estimates of $84.05 million. AngioDynamics had a return on equity of 5.44% and a net margin of 4.62%. The firm’s revenue was down .1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.13 earnings per share. On average, sell-side analysts expect that AngioDynamics, Inc. will post 0.85 EPS for the current fiscal year.

Several institutional investors and hedge funds have recently made changes to their positions in ANGO. Millennium Management LLC acquired a new position in shares of AngioDynamics in the 1st quarter worth approximately $3,787,000. Royal Bank of Canada lifted its holdings in AngioDynamics by 3.3% during the 1st quarter. Royal Bank of Canada now owns 126,439 shares of the medical instruments supplier’s stock worth $2,181,000 after buying an additional 3,981 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in AngioDynamics by 2.7% during the 1st quarter. Principal Financial Group Inc. now owns 298,168 shares of the medical instruments supplier’s stock worth $5,143,000 after buying an additional 7,871 shares in the last quarter. Port Capital LLC lifted its holdings in AngioDynamics by 32.5% during the 2nd quarter. Port Capital LLC now owns 16,325 shares of the medical instruments supplier’s stock worth $363,000 after buying an additional 4,000 shares in the last quarter. Finally, First National Bank of Omaha acquired a new position in AngioDynamics during the 2nd quarter worth $775,000. 97.54% of the stock is currently owned by institutional investors and hedge funds.

Several research analysts have recently commented on ANGO shares. BidaskClub raised AngioDynamics from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 24th. Zacks Investment Research raised AngioDynamics from a “sell” rating to a “hold” rating in a report on Tuesday, September 11th. Four analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. AngioDynamics has a consensus rating of “Buy” and a consensus target price of $18.44.

COPYRIGHT VIOLATION WARNING: “AngioDynamics, Inc. (ANGO) CFO Sells $41,746.67 in Stock” was posted by Community Financial News and is the property of of Community Financial News. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://www.com-unik.info/2018/11/10/angiodynamics-inc-ango-cfo-sells-41746-67-in-stock.html.

About AngioDynamics

AngioDynamics, Inc designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support.

Read More: Bull Market

Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit